Ascendis Pharma is a biopharmaceutical company committed to developing innovative therapies to address unmet medical needs, with a focus on patients suffering from rare diseases. Utilizing its proprietary TransCon technology, Ascendis Pharma is building a fully integrated company that combines research, development, and commercialization of novel treatments. With locations across Europe and the United States, the company operates with core values centered on patients, science, and passion. Ascendis Pharma is dedicated to delivering potentially best-in-class therapeutics, supported by a growing pipeline of prodrug therapies in various stages of development. The organization fosters an environment that encourages collaboration, innovation, and professional growth, offering diverse opportunities across multiple disciplines such as research, product development, and commercial strategies.